InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

Oh, I could have used the extra propulsion of an e-bike about a dozen years ago. But there I was in Washington County, Virginia, between Alvarado and Watauga — trying to grind power out of a ...

The FDA, which usually adheres to the recommendations ... the holder of Zynquista’s marketing rights in the region, Guidehouse Germany GmbH, withdrew (PDF) the marketing authorization, saying ...

BEIJING (AP) — The United States, Germany and France have called for the release of a Chinese human rights lawyer and his wife who were sentenced to prison this week for alleged subversion. On Tuesday ...

The FDA approval is based on the results of the open-label KEYNOTE-224 trial, which enrolled 104 patients who had relapsed after or were refractory to Bayer’s Nexavar (sorafenib), the first-line ...

ST. LOUIS — A newly FDA-approved procedure allows patients to regrow their own knee cartilage using autologous cell implantation. The treatment, known as MACI (Matrix Autologous Chondrocyte ...